Sotera launches learning resource for sterilisation and lab testing
Several hours of content from introductory sterilisation and lab testing topics to more advanced, in-depth learning are covered by the academy
Sotera Health Company, a global provider of sterilisation solutions, lab testing, and advisory services for the healthcare industry, has announced the launch of the ‘Sotera Health Academy’. The academy combines content curated by professionals from the group’s three businesses: Nelson Labs, Sterigenics, and Nordion, designed to help companies mitigate regulatory risk and enhance product speed to market.
Several hours of content from introductory sterilisation and lab testing topics to more advanced, in-depth learning are covered by the academy. The resource includes 150 webinars, whitepapers, and eBooks from more than 75 industry experts with more material being added. With the company’s recent acquisition of Regulatory Compliance Associates (RCA), a premier provider of quality and regulatory advisory services, additional expert content will be forthcoming to the Academy.
“From product conception to commercialisation, each stage in the lifecycle of a medical device, pharmaceutical, or commercial product poses unique challenges for manufacturers, especially when patient safety is paramount,” said Jeffery R. Nelson, Chairman, Nelson Labs. “The free educational resources contained in the Sotera Health Academy cover a wide range of key topics to help customers build the knowledge they need for today and prepare them for the regulatory requirements of tomorrow so they can confidently achieve their company’s goals.”
“The Sotera Health Academy provides proven insights from some of the industry’s foremost thought leaders,” said Michael B. Petras, Jr., Chairman and CEO, Sotera Health. “Our highly qualified team of expert advisors offers an unparalleled range of experience acquired from helping thousands of healthcare companies bring their products confidently and safely to market. Our new educational platform will be critical to companies as they navigate an increasingly complex regulatory landscape.”
